(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNAPSE MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SYNAPSE MEDICINE

ST13

US500000088913042

Class

9, 42

Filing

88913042

Registration

6662240

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

03/08/2022

Trademark type

Combined

Nice classes

9, 42

Filing date

05/12/2020

Registration date

03/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

03/08/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

99

Owner location

33000, FR

Examiner

SMITH, REBECCA A

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "SYNAPSE MEDICINE" in blue to the right of a geometric design in blue and white.

Holders and representatives

Holders

S. M. (pessoa física)

Representatives

Todd A. Denys PORZIO, BROMBERG & NEWMAN, P.C.

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software using artificial intelligence for word processing and establishing standardized directories in the field of healthcare; Downloadable computer software using artificial intelligence for medical prescription assistancesoftware for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for drug interaction preventionsoftware for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysissoftware for word processing and establishing standardized directories

Class 42

Research in the field of artificial intelligence for computer software design for healthcarefor medical prescription assistancefor drug interaction prevention and for prescriptions analysis; Software design and development for healthcarefor medical prescription assistancefor drug interaction prevention and for prescriptions analysis; Software as a service (SAAS) services featuring artificial intelligence software for word processing and establishing standardized directories in the fields of healthcaremedical prescription assistancedrug interaction prevention and prescriptions analysis

Publications

History of USPTO decisions and trademark events.

22 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/21/2021

PUBO

PUBLISHED FOR OPPOSITION

12/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/18/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/17/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/17/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/17/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/04/2021

GNRT

NON-FINAL ACTION E-MAILED

06/04/2021

CNRT

NON-FINAL ACTION WRITTEN

06/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/18/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/18/2021

ALIE

ASSIGNED TO LIE

05/17/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/09/2020

GNRT

NON-FINAL ACTION E-MAILED

08/09/2020

CNRT

NON-FINAL ACTION WRITTEN

08/09/2020

DOCK

ASSIGNED TO EXAMINER

08/07/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/27/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/26/2020

NWAP

NEW APPLICATION ENTERED

05/15/2020

Continuous trademark protection

Get notified about every new filing that threatens SYNAPSE MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.